Study of High Efficient Killing Cell Therapy for Advanced NSCLC

Inclusion Criteria: * Male or female patients' age from 18 years to 70 years. * Patients who have a life expectancy of at least 3 months. * pathologically confirmed non-small cell lung cancer. * failed in previous standard chemotherapy and targeted therapy. * Karnofsky performance status 0-1. * adequate organ functions. Exclusion Criteria: * Pregnant and lactating women. * Patients with T cell lymphoma, syphilis, AIDS or combination * Patients with highly allergic or have a history of severe allergies * Patients with severe hepatic or renal dysfunction * Patients with severe autoimmune disease or who is being treated with immunosuppressive agents * Patients with severe infection not controlled or High fever * Patients with organ transplantation or waiting for organ transplantation. * Patients with brain metastasis * Patients with severe coagulopathy (e.g. hemophilia) * Patients without adequate ability to understand, sign informed consents and take part in the clinical research voluntarily.